PREDICT-LAA was presented in Boston on Saturday 17th 2022 by Pr. Ole De Backer. Dr. Philippe GAROT (ICPS) is co-primary investigator of the Study.
This trial showed for the first time the added value of AI-enabled, CT-based computational modelling when planning for percutaneous #LAA closure – with markedly improved procedural efficiency, efficacy & safety outcomes. This is a breakthrough and could lead the way, in general, on how to optimize outcomes of device implantations in the future.